Mobile Site ›
Communique Print the PDF of this entire issue

New Tests


November 2014


New tests are continually developed by the clinical and research laboratories of Mayo Clinic. These tests are subjected to an intense laboratory and clinical correlative process to ensure their diagnostic utility prior to their release.

Significant new test announcements are included with each Communiqué issue to provide both clinical and technical information in a single document.

The following tests are described in this month's Communiqué:

3A5B / CYP3A5 Genotype, Blood

  • Useful for: An aid in optimizing treatment with tacrolimus and potentially other drugs metabolized by CYP3A5 ....more>>

3A5O / CYP3A5 Genotype, Saliva

  • Useful for: An aid in optimizing treatment with tacrolimus and potentially other drugs metabolized by CYP3A5 ...more>>

HYDCU / Hydrocodone with Metabolite Confirmation, Urine

  • Useful for: Detection and quantification of hydrocodone and hydromorphone in urine ...more>>

HYDMU / Hydromorphone Confirmation, Urine

  • Useful for: Detection and quantification of hydromorphone in urine ...more>>

OXYSU / Oxycodone Screen, Urine

  • Useful for: Detection of oxycodone and oxymorphone in urine ...more>>

OXYSX / Oxycodone Screen, Chain of Custody, Urine

  • Useful for: Detection of oxycodone and oxymorphone in urine following chain-of-custody procedures ...more>>

OXYCU / Oxycodone with Metabolite Confirmation, Urine

  • Useful for: Detection and quantification of oxycodone and oxymorphone in urine ...more>>

OXYCX / Oxycodone with Metabolite Confirmation, Chain of Custody, Urine

  • Useful for: Detection and quantification of oxycodone and oxymorphone in urine ...more>>

OXYMU / Oxymorphone Confirmation, Urine

  • Useful for: Detection and quantification of oxymorphone in urine ...more>>

FPLAS / Plasma Cell Proliferative Disorder, FISH, Tissue

  • Useful for: Supporting the diagnosis of plasmacytoma when coordinated with a surgical pathology consultation ...more>>

Key